Molina Healthcare, Inc. (MOH) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held by Molina Healthcare, Inc. on May 3, 2023. The filing was submitted on May 5, 2023. The meeting addressed the election of directors, executive compensation, and the ratification of the independent auditor.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent Form 10-Q or 10-K for financial results.
Material Changes and Voting Results
The filing details the outcomes of four proposals voted on by stockholders. A total of 54,488,955 shares were voted, representing 93.51% of the 58,268,825 shares outstanding as of the March 8, 2023 record date.
- Proposal 1 (Election of Directors): All nine nominated directors were elected. While all were approved, two directors received significant "Against" votes:
- Ronna E. Romney: 7,110,442 votes against (13.0% of votes cast).
- Dale B. Wolf: 5,309,971 votes against (9.7% of votes cast).
- Steven J. Orlando: 4,488,986 votes against (8.1% of votes cast).
- Proposal 2 (Say-on-Pay): Stockholders approved the non-binding advisory vote on executive compensation.
- For: 44,548,396 (81.8%)
- Against: 7,888,118 (14.5%)
- Proposal 3 (Frequency of Say-on-Pay): Stockholders voted to hold the advisory vote on executive compensation annually.
- One Year: 51,720,836 (95.0%)
- Three Years: 708,345 (1.3%)
- Proposal 4 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2023.
- For: 52,159,920 (95.7%)
- Against: 2,320,473 (4.3%)
Guidance, Outlook, and Risks
This filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. It is strictly a report of the stockholder meeting results.
Key Facts for Investor Verification
- Verify the reasons behind the elevated "Against" votes for directors Ronna E. Romney, Dale B. Wolf, and Steven J. Orlando, as these dissent rates are notably higher than for other nominees.
- Confirm the company's response to the 14.5% "Against" vote on the executive compensation proposal (Say-on-Pay).
- Note that the stockholders have mandated an annual frequency for future Say-on-Pay votes.
- Review the company's latest quarterly or annual report for financial performance data, as this 8-K contains none.